IL129623A0 - Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes - Google Patents

Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Info

Publication number
IL129623A0
IL129623A0 IL12962397A IL12962397A IL129623A0 IL 129623 A0 IL129623 A0 IL 129623A0 IL 12962397 A IL12962397 A IL 12962397A IL 12962397 A IL12962397 A IL 12962397A IL 129623 A0 IL129623 A0 IL 129623A0
Authority
IL
Israel
Prior art keywords
syndromes
prevention
treatment
related diseases
derivatives useful
Prior art date
Application number
IL12962397A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL129623A0 publication Critical patent/IL129623A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL12962397A 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes IL129623A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK120196 1996-10-28
PCT/DK1997/000481 WO1998018774A1 (en) 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Publications (1)

Publication Number Publication Date
IL129623A0 true IL129623A0 (en) 2000-02-29

Family

ID=8102120

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12962397A IL129623A0 (en) 1996-10-28 1997-10-28 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

Country Status (8)

Country Link
EP (1) EP0937059A1 (no)
JP (1) JP2001502706A (no)
AU (1) AU744403B2 (no)
CA (1) CA2269936A1 (no)
IL (1) IL129623A0 (no)
NO (1) NO992009L (no)
WO (1) WO1998018774A1 (no)
ZA (1) ZA979643B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69716292T2 (de) * 1996-12-13 2003-07-03 Chugai Pharmaceutical Co Ltd Benzopyranderivate
KR100615757B1 (ko) * 1998-12-30 2006-08-25 시그날 파마소티칼 아이엔씨 에스트로겐 수용체를 조절하는 화합물 및 방법
HUP0401018A3 (en) * 2001-01-24 2007-05-29 Chiesi Farma Spa 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
NZ553834A (en) 2004-09-21 2010-03-26 Novogen Res Pty Ltd 7-hydroxy-3,4-diphenyl-chroman and chromene derivatives
JP4976649B2 (ja) * 2004-09-21 2012-07-18 マーシャル エドワーズ，インク． 化合物
WO2012061409A1 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
ES2877712T3 (es) 2015-02-02 2021-11-17 Mei Pharma Inc Terapias combinadas para su uso en el tratamiento del cáncer de mama

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
DE1543749A1 (de) * 1966-02-16 1969-12-11 Merck Ag E Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
HUP9702244A3 (en) * 1995-01-13 1999-12-28 Novo Nordisk As Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Also Published As

Publication number Publication date
WO1998018774A1 (en) 1998-05-07
AU744403B2 (en) 2002-02-21
JP2001502706A (ja) 2001-02-27
ZA979643B (en) 1998-04-28
NO992009L (no) 1999-06-25
EP0937059A1 (en) 1999-08-25
AU4771897A (en) 1998-05-22
CA2269936A1 (en) 1998-05-07
NO992009D0 (no) 1999-04-27

Similar Documents

Publication Publication Date Title
AU4966497A (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
HUP9900790A3 (en) Imidazoquinazoline derivatives
ZA9710322B (en) Process for the preparation of benzyl-ethers.
AU8181798A (en) Adjustable leg
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
IL129623A0 (en) Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA984177B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
IL129622A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129624A0 (en) Novel (+)-enantiomers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129618A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU663832B2 (en) Easy chess-like game
IL129626A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
IL129617A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
GB2322785B (en) Pasteurizing process
HK1004660A1 (en) Composition for treating hyperosteogeny and process for the preparation thereof
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
AU7639998A (en) Pyrrolo{2,1,5-cd}indolizine derivatives useful in the prevention or treatment ofestrogen related diseases or syndromes
ZA984823B (en) Pyrrolo(2,1,5-cd)indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA984822B (en) Pyrrolo (2,11,5-cd) indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA975061B (en) Manufacture of articles.
IL108277A0 (en) 3-Metyl-7-n-propylxantihine derivatives and processes for the preparation thereof
AU7539596A (en) Oxaindene derivatives and process for the preparation thereof